# Rare Earths Americas, Inc.: financial statements, quarterly

REA · NYSE · CIK 2095743 · [Materials](/sectors/materials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/rea.md) · [Financials](/companies/rea/financials.md) · [Filings](/companies/rea/filings.md) · [Insiders](/companies/rea/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/rea/financials.md?period=annual).

## Income statement

| Line item | Unit | period not labelled (2025-03-31) | period not labelled (2025-06-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: |
| Operating income | $m | [(0.3)](/filings/0001193125-26-257598.md) | [(0.5)](/filings/0001193125-26-344825.md) | [(4.8)](/filings/0001193125-26-257598.md) | [(12.8)](/filings/0001193125-26-344825.md) |
| Interest expense | $m | [0.0](/filings/0001193125-26-257598.md) | [0.1](/filings/0001193125-26-344825.md) | [0.0](/filings/0001193125-26-257598.md) | [0.0](/filings/0001193125-26-344825.md) |
| Income tax | $m | not reported | [0.0](/filings/0001193125-26-344825.md) | [0.0](/filings/0001193125-26-257598.md) | [0.0](/filings/0001193125-26-344825.md) |
| Net income | $m | [(0.3)](/filings/0001193125-26-344825.md) | [(0.6)](/filings/0001193125-26-344825.md) | [(16.8)](/filings/0001193125-26-344825.md) | [(12.8)](/filings/0001193125-26-344825.md) |
| Diluted EPS | $ per share | [(0.03)](/filings/0001193125-26-257598.md) | [(0.06)](/filings/0001193125-26-344825.md) | [(1.12)](/filings/0001193125-26-257598.md) | [(0.70)](/filings/0001193125-26-344825.md) |
| Basic EPS | $ per share | [(0.03)](/filings/0001193125-26-257598.md) | [(0.06)](/filings/0001193125-26-344825.md) | [(1.12)](/filings/0001193125-26-257598.md) | [(0.70)](/filings/0001193125-26-344825.md) |

- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | period not labelled (2024-12-31) | period not labelled (2025-03-31) | period not labelled (2025-06-30) | period not labelled (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | not reported | not reported | not reported | [22.8](/filings/0001193125-26-344825.md) | [20.4](/filings/0001193125-26-257598.md) | [10.1](/filings/0001193125-26-344825.md) |
| Current assets | $m | not reported | not reported | not reported | [23.1](/filings/0001193125-26-344825.md) | [20.8](/filings/0001193125-26-257598.md) | [78.0](/filings/0001193125-26-344825.md) |
| Total assets | $m | not reported | not reported | not reported | [48.8](/filings/0001193125-26-344825.md) | [47.4](/filings/0001193125-26-257598.md) | [102](/filings/0001193125-26-344825.md) |
| Current liabilities | $m | not reported | not reported | not reported | [3.9](/filings/0001193125-26-344825.md) | [3.1](/filings/0001193125-26-257598.md) | [2.5](/filings/0001193125-26-344825.md) |
| Total liabilities | $m | not reported | not reported | not reported | [20.4](/filings/0001193125-26-344825.md) | [35.6](/filings/0001193125-26-257598.md) | [15.1](/filings/0001193125-26-344825.md) |
| Shareholders' equity | $m | [(0.3)](/filings/0001193125-26-344825.md) | [(0.5)](/filings/0001193125-26-344825.md) | [(1.1)](/filings/0001193125-26-344825.md) | [26.2](/filings/0001193125-26-344825.md) | [9.5](/filings/0001193125-26-257598.md) | [85.0](/filings/0001193125-26-344825.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Shareholders' equity: us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest, us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | period not labelled (2025-03-31) | period not labelled (2025-06-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: |
| Operating cash flow | $k | [112](/filings/0001193125-26-257598.md) | [144 d](/filings/0001193125-26-344825.md) | [(4,426)](/filings/0001193125-26-257598.md) | [(5,839) d](/filings/0001193125-26-344825.md) |
| Capital expenditure | $k | [0.0](/filings/0001193125-26-257598.md) | [2.0 d](/filings/0001193125-26-344825.md) | [157](/filings/0001193125-26-257598.md) | [257 d](/filings/0001193125-26-344825.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment

## Shares

| Line item | Unit | period not labelled (2025-03-31) | period not labelled (2025-06-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [9.4](/filings/0001193125-26-257598.md) | [9.4](/filings/0001193125-26-344825.md) | [15.0](/filings/0001193125-26-257598.md) | [18.2](/filings/0001193125-26-344825.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 19,953,892 at 2026-08-10, from the cover of the [10-Q filed 2026-08-11](/filings/0001193125-26-344825.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:51 ET. No prices; not investment advice.